The MolecuLight i:X™ Imaging Device is approved by Health Canada (Medical License #95784) and has CE marking (Certificate #G1160292355002) for sale in Canada and the European Union. The MolecuLight i:X™ Imaging Device has received FDA De Novo clearance.
DaCosta RS, Kulbatski I, Lindvere-Teene L, Starr D, Blackmore K, Silver JI, Opoku J, Wu YC, Medeiros PJ, Xu W, Xu L, Wilson BC, Rosen C, Linden R. Point-of-care autofluorescence imaging for real-time sampling and treatment guidance of bioburden in chronic wounds: first-in-human results. PLOS ONE, 2015, 10(2). doi: 10.1371/journal.pone.0116623.
Blumenthal E, Jeffery SLA. Autofluorescence imaging for evaluating debridement in military and trauma wounds. Military Medicine, 2018, 183(3/4), 429-432. doi: 10.1093/milmed/usx145.